Experimental Alzheimer’s drug slows cognitive decline in late-stage trial; Eli Lilly Home News May 4, 2023 United States: Pharmaceutical company Eli Lilly has announced the successful results of a late-stage clinical trial of its experimental drug…
Alzheimer’s drug Lecanemab hailed as a landmark breakthrough Home News November 30, 2022 Massachusetts: Lecanemab, the drug which is designed to target and clear amyloid, has become the first drug to slow the…
